C5a treatment induced neuronal apoptosis under OGD conditions, while C5aR1 deficiency prevented neurons from OGD-induced apoptosis, suggesting that inhibiting the interaction between C5a and C5aR1 was neuroprotective in the acute phase of ischemic stroke [285]. This evidence concerns the gene C5 and ischemic stroke.